Cargando…

No Causal Link between Phosphodiesterase Type 5 Inhibition and Melanoma

PURPOSE: To examine the association between phosphodiesterase type 5 (PDE5) inhibitor use and melanoma by 1) conducting a systematic review of observational studies; and 2) determining if low PDE5A gene expression in human melanoma correlated with decreased overall survival. MATERIALS AND METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jenny Z., Le, Stephanie, Alexanian, Claire, Boddu, Sucharita, Merleev, Alexander, Marusina, Alina, Maverakis, Emanual
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Sexual Medicine and Andrology 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704303/ https://www.ncbi.nlm.nih.gov/pubmed/30350485 http://dx.doi.org/10.5534/wjmh.180050

Ejemplares similares

2D Visualization of the Psoriasis Transcriptome Fails to Support the Existence of Dual-Secreting IL-17A/IL-22 Th17 T Cells
por: Le, Stephanie T., et al.
Publicado: (2019)

Dual mTOR Inhibition Is Required to Prevent TGF-β-Mediated Fibrosis: Implications for Scleroderma
por: Mitra, Anupam, et al.
Publicado: (2015)

Transcriptome analysis of human dermal fibroblasts following red light phototherapy
por: Austin, Evan, et al.
Publicado: (2021)

Incidence, Clinical Features, Management, and Prevention of Herpes Zoster in Patients Receiving Antitumor Necrosis Factor Therapy: A Clinical Review
por: Kim, Byung-Soo, et al.
Publicado: (2020)

Virally encoded interleukin-6 facilitates KSHV replication in monocytes and induction of dysfunctional macrophages
por: Shimoda, Michiko, et al.
Publicado: (2023)

Classic Ulcerative Pyoderma Gangrenosum Is a T Cell-Mediated Disease Targeting Follicular Adnexal Structures: A Hypothesis Based on Molecular and Clinicopathologic Studies
por: Wang, Elizabeth A., et al.
Publicado: (2018)

A Comparison of Ex Vivo Expanded Human Regulatory T Cells Using Allogeneic Stimulated B Cells or Monocyte-Derived Dendritic Cells
por: Lee, Linda M., et al.
Publicado: (2021)

Biogeographic and disease-specific alterations in epidermal lipid composition and single-cell analysis of acral keratinocytes
por: Merleev, Alexander A., et al.
Publicado: (2022)

A site-specific map of the human plasma glycome and its age and gender-associated alterations
por: Merleev, Alexander A., et al.
Publicado: (2020)

Proprotein convertase subtilisin/kexin type 9 is a psoriasis-susceptibility locus that is negatively related to IL36G
por: Merleev, Alexander, et al.
Publicado: (2022)

Red Light Phototherapy Using Light-Emitting Diodes Inhibits Melanoma Proliferation and Alters Tumor Microenvironments
por: Austin, Evan, et al.
Publicado: (2022)

Mechanisms by Which Obesity Promotes Acute Graft-Versus-Host Disease in Mice
por: Khuat, Lam T., et al.
Publicado: (2021)

Quantitative glycoproteomics of high-density lipoproteins
por: Tang, Xinyu, et al.
Publicado: (2022)

Treatment of melanoma in-transit metastases with combination intralesional interleukin-2, topical imiquimod, and tretinoin 0.1% cream
por: Leventhal, Jonathan S., et al.
Publicado: (2016)

Combined Immune Checkpoint Blockade and Stereotactic Ablative Radiotherapy Can Stimulate Response to Immunotherapy in Metastatic Melanoma: A Case Report
por: Moran, Angel, et al.
Publicado: (2019)

Sentinel Lymph Node Biopsy in Patients with Thick Primary Cutaneous Melanoma: Patterns of Use and Underuse Utilizing a Population-Based Model
por: Martinez, Steve R., et al.
Publicado: (2013)

Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial
por: Monjazeb, Arta M., et al.
Publicado: (2023)

Is It Possible to Discontinue Tumor Necrosis Factor Antagonists after Psoriasis Remission?
por: Kim, Byungsoo, et al.
Publicado: (2019)

MEK inhibitors and their potential in the treatment of advanced melanoma: the advantages of combination therapy
por: Tran, Khiem A, et al.
Publicado: (2015)

Clinical Implication of Phosphodiesterase-4-Inhibition
por: Schick, Martin Alexander, et al.
Publicado: (2022)

Urogynecologic complications in Stevens-Johnson syndrome and toxic epidermal necrolysis: Presentation of a case and recommendations for management
por: Petukhova, Tatyana A., et al.
Publicado: (2016)

Use of sildenafil or other phosphodiesterase inhibitors and risk of melanoma
por: Pottegård, Anton, et al.
Publicado: (2016)

A proximity labeling method for protein–protein interactions on cell membrane
por: Li, Qiongyu, et al.
Publicado: (2022)

Defining novel causal SNPs and linked phenotypes at melanoma-associated loci
por: Castaneda-Garcia, Carolina, et al.
Publicado: (2022)

Phosphodiesterase-4 Inhibition in Psoriasis
por: Milakovic, Milica, et al.
Publicado: (2021)

Meta-Analysis of the Association Between Phosphodiesterase Inhibitors (PDE5Is) and Risk of Melanoma
por: Loeb, Stacy, et al.
Publicado: (2017)

Reply to “Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era”
por: Lang, Claudia Cécile Valérie, et al.
Publicado: (2021)

Soluble CD40L activates soluble and cell-surface integrin αvβ3, α5β1, and α4β1 by binding to the allosteric ligand-binding site (site 2)
por: Takada, Yoko K., et al.
Publicado: (2021)

T Cell Receptor Complementarity Determining Region 3 Length Analysis Reveals the Absence of a Characteristic Public T Cell Repertoire in Neonatal Tolerance: The Response in the “Tolerant” Mouse within the Residual Repertoire Is Quantitatively Similar but Qualitatively Different
por: Maverakis, Emanual, et al.
Publicado: (2000)

Phosphodiesterase-5 inhibition and cardioprotection: potential role of hydrogen sulfide
por: Kukreja, Rakesh C, et al.
Publicado: (2009)

Inhibition of phosphodiesterase 5 restores endothelial function in renovascular hypertension
por: Dias, Ananda T, et al.
Publicado: (2014)

Stimulation of Neural Stem Cell Proliferation by Inhibition of Phosphodiesterase 5
por: Santos, Ana I., et al.
Publicado: (2014)

Characterization of phosphodiesterase 2A in human malignant melanoma PMP cells
por: MORITA, HIROSHI, et al.
Publicado: (2013)

Exuberant scale crust of the scalp
por: Kao, Jason, et al.
Publicado: (2018)

Use of phosphodiesterase type 5 inhibitors and risk of melanoma: a meta-analysis of observational studies
por: Han, Xinming, et al.
Publicado: (2018)

Relation of phosphodiesterase type 5 inhibitors and malignant melanoma: a meta-analysis and systematic review
por: Wang, Jie, et al.
Publicado: (2017)

Phosphodiesterase 3 inhibition and cough in elderly asthmatics
por: Ishiura, Yoshihisa, et al.
Publicado: (2005)

BIOLOGICAL THERAPY OF PSORIASIS
por: Sivamani, Raja K, et al.
Publicado: (2010)

Effect of phosphodiesterase inhibitors in the bladder
por: Chughtai, Bilal, et al.
Publicado: (2015)

Erectogenic Effects of Clerodendron capitatum: Involvement of Phosphodiesterase Type-5 Inhibition
por: Abdelwahab, Siddig Ibrahim, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_q45ssobi76b3opjvd79u1kjert